NIH-funded research NIH-funded research

How changes in red blood cell function affect heart health in kidney disease patients

Official title: Dynamic Changes in Erythrocyte 2,3 DPG as a Driver of Cardiac Dysfunction in End Stage Kidney Disease

Funded at VA Greater Los Angeles Healthcare System · NIH-10909836 · Data updated 2026-11-12

This study is looking at how changes in certain substances in your red blood cells might affect heart health for people with severe kidney disease who are on dialysis, with the goal of finding better ways to help keep your heart healthy.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Greater Los Angeles Healthcare System
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJuly 1, 2021
Project endJune 30, 2026
Funding year2024
NIH project number5IK2CX002195-04
Project IDNIH-10909836 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are veterans and other patients undergoing hemodialysis for end-stage renal disease.

Less likely to help

Patients who are not on dialysis or those with early-stage kidney disease may not benefit from this research.

What this research studies

This research investigates how alterations in red blood cell metabolites, specifically 2,3-DPG, contribute to heart problems in patients with end-stage renal disease (ESRD) undergoing dialysis. By examining the relationship between these changes and cardiovascular events, the study aims to identify new therapeutic strategies to improve heart health in this vulnerable population. The research will utilize both laboratory models and patient data to explore these connections and their implications for treatment.

Why it matters

Potential benefit: If successful, this research could lead to improved cardiovascular outcomes and reduced mortality for patients with end-stage kidney disease.

How similar studies have gone: Previous research has shown promising results in understanding the cardiovascular risks associated with dialysis, suggesting that this approach may yield valuable insights.

Where this research is happening

  • VA Greater Los Angeles Healthcare System
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Sharma, Shilpa — VA Greater Los Angeles Healthcare System
  • Study coordinator: Sharma, Shilpa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.